Tenecteplase biosimilar (Generium Pharmaceuticals)
替奈普酶生物类似药 (Generium Pharmaceuticals)
Report date: 2022/11/14 13:45:27
Base Information
Drug NameTenecteplase biosimilar (Generium Pharmaceuticals)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesGenerium Pharmaceuticals
China Registration ClassN/A
Develop Information
Active CompaniesGenerium Pharmaceuticals
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A